|
1
|
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
|
Radiology
|
2003
|
3.71
|
|
2
|
Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging.
|
Methods Enzymol
|
2004
|
1.82
|
|
3
|
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.
|
Blood
|
2004
|
1.76
|
|
4
|
MRI detects white matter reorganization after neural progenitor cell treatment of stroke.
|
Neuroimage
|
2006
|
1.69
|
|
5
|
Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat.
|
Wound Repair Regen
|
2006
|
1.58
|
|
6
|
Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging.
|
NMR Biomed
|
2006
|
1.58
|
|
7
|
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
|
Nat Med
|
2012
|
1.53
|
|
8
|
Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
|
J Pharmacol Exp Ther
|
2007
|
1.53
|
|
9
|
Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI.
|
J Magn Reson Imaging
|
2007
|
1.42
|
|
10
|
Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI.
|
Neuroimage
|
2005
|
1.41
|
|
11
|
In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy.
|
Stem Cells
|
2008
|
1.41
|
|
12
|
Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
|
Stem Cells
|
2010
|
1.29
|
|
13
|
Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.
|
PLoS One
|
2010
|
1.24
|
|
14
|
Optimization and validation of FePro cell labeling method.
|
PLoS One
|
2009
|
1.19
|
|
15
|
9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
|
J Pharmacol Exp Ther
|
2005
|
1.19
|
|
16
|
The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
|
Arthritis Rheum
|
2007
|
1.16
|
|
17
|
Measurement of quantity of iron in magnetically labeled cells: comparison among different UV/VIS spectrometric methods.
|
Biotechniques
|
2007
|
1.15
|
|
18
|
Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.
|
Biochem Pharmacol
|
2009
|
1.08
|
|
19
|
Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis.
|
Ann Neurol
|
2004
|
1.07
|
|
20
|
Model selection for DCE-T1 studies in glioblastoma.
|
Magn Reson Med
|
2011
|
1.06
|
|
21
|
Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
|
Carcinogenesis
|
2011
|
1.05
|
|
22
|
Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats.
|
Int Wound J
|
2008
|
1.03
|
|
23
|
Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo.
|
J Pharmacol Exp Ther
|
2008
|
1.03
|
|
24
|
Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.
|
PLoS One
|
2010
|
1.02
|
|
25
|
The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization.
|
ScientificWorldJournal
|
2010
|
0.98
|
|
26
|
A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma.
|
Nanomedicine (Lond)
|
2012
|
0.97
|
|
27
|
Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats.
|
Radiology
|
2005
|
0.96
|
|
28
|
Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.
|
Anticancer Res
|
2010
|
0.95
|
|
29
|
Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
|
Arthritis Rheum
|
2013
|
0.94
|
|
30
|
Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
|
Anticancer Res
|
2011
|
0.93
|
|
31
|
AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study.
|
BMC Biotechnol
|
2009
|
0.91
|
|
32
|
Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.
|
J Neurooncol
|
2012
|
0.90
|
|
33
|
Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings.
|
Stem Cells Transl Med
|
2013
|
0.89
|
|
34
|
Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.
|
Biochem Biophys Res Commun
|
2012
|
0.89
|
|
35
|
ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.
|
Anticancer Res
|
2013
|
0.87
|
|
36
|
Effects of ferumoxides-protamine sulfate labeling on immunomodulatory characteristics of macrophage-like THP-1 cells.
|
PLoS One
|
2008
|
0.87
|
|
37
|
Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.
|
Cancers (Basel)
|
2011
|
0.86
|
|
38
|
Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma.
|
PLoS One
|
2012
|
0.86
|
|
39
|
The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood.
|
J Pharmacol Exp Ther
|
2011
|
0.85
|
|
40
|
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer.
|
Cancers (Basel)
|
2010
|
0.84
|
|
41
|
Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent.
|
Molecules
|
2013
|
0.83
|
|
42
|
MRI detects brain reorganization after human umbilical tissue-derived cells (hUTC) treatment of stroke in rat.
|
PLoS One
|
2012
|
0.83
|
|
43
|
Cord blood endothelial progenitor cells as therapeutic and imaging probes.
|
Imaging Med
|
2012
|
0.82
|
|
44
|
MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma.
|
PLoS One
|
2012
|
0.82
|
|
45
|
20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.
|
J Pharmacol Exp Ther
|
2014
|
0.82
|
|
46
|
Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
|
Molecules
|
2012
|
0.81
|
|
47
|
Investigation of relationships between transverse relaxation rate, diffusion coefficient, and labeled cell concentration in ischemic rat brain using MRI.
|
Magn Reson Med
|
2009
|
0.81
|
|
48
|
Color transformation and fluorescence of Prussian blue-positive cells: implications for histologic verification of cells labeled with superparamagnetic iron oxide nanoparticles.
|
Mol Imaging
|
2007
|
0.80
|
|
49
|
Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
|
J Exp Ther Oncol
|
2014
|
0.80
|
|
50
|
Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo.
|
Chin J Cancer
|
2013
|
0.79
|
|
51
|
Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis.
|
Arthritis Res Ther
|
2014
|
0.79
|
|
52
|
Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
|
Oncol Res
|
2008
|
0.79
|
|
53
|
Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
|
J Exp Ther Oncol
|
2012
|
0.78
|
|
54
|
Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71.
|
Biotechnol Res Int
|
2013
|
0.78
|
|
55
|
Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection.
|
J Magn Reson Imaging
|
2014
|
0.77
|
|
56
|
Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer.
|
Anticancer Agents Med Chem
|
2015
|
0.77
|
|
57
|
Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma.
|
BMC Med Imaging
|
2013
|
0.76
|
|
58
|
Iron oxide-transfection agent complexes are not expected to coat the cell membrane and prevent CD71 expression.
|
Radiology
|
2008
|
0.75
|
|
59
|
Bone marrow-derived stromal cells (BMSCs) interact with fibroblasts in accelerating wound healing.
|
J Invest Surg
|
2009
|
0.75
|